Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: A meta-analysis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Gu, Xiao Bin ^a   Tian, Tian ^a   Tian, Xiao Jing ^a   Zhang, Xiao Jun ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LUNG TUMOR; LYMPHOCYTE; LYMPHOCYTE COUNT; MALE; META ANALYSIS; MORTALITY; NEUTROPHIL; NON SMALL CELL LUNG CANCER; SURVIVAL RATE;

CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; NEUTROPHILS; SURVIVAL RATE;

EID: 84937941802     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12493     Document Type: Article

References (42)

1. Jemal, A. et al. Global Cancer Statistics. CA-Cancer J. Clin. 61, 69-90, doi: 10.3322/caac.20107 (2011).
2. Siegel, R. et al. Cancer treatment and survivorship statistics, 2012. CA-Cancer J. Clin. 62, 220-241, doi:10.3322/caac.21149 (2012).
3. Paesmans, M. et al. Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 13, 1221-1230 (1995).
4. Proctor, M. J. et al. The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study. British journal of cancer 103, 870-876, doi: 10.1038/sj.bjc.6605855 (2010).
5. Sieghart, W. et al. Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma. Hepatology 57, 2224-2234, doi: 10.1002/hep.26057 (2013).
6. Gomez, D., Morris-Stiff, G., Toogood, G. J., Lodge, J. P. & Prasad, K. R. Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol 97, 513-518, doi: 10.1002/jso.21001 (2008).
7. Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860-867, doi: 10.1038/nature01322 (2002).
8. McMillan, D. C. The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer. Cancer treatment reviews 39, 534-540, doi: 10.1016/j.ctrv.2012.08.003 (2013).
9. Sugiura, T., Uesaka, K., Kanemoto, H., Mizuno, T. & Okamura, Y. Elevated Preoperative Neutrophil-to-lymphocyte Ratio as a Predictor of Survival After Gastroenterostomy in Patients with Advanced Pancreatic Adenocarcinoma. Annals of surgical oncology 20, 4330-4337, doi: 10.1245/s10434-013-3227-8 (2013).
10. De Larco, J. E., Wuertz, B. R. & Furcht, L. T. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clinical cancer research : an official journal of the American Association for Cancer Research 10, 4895-4900, doi: 10.1158/1078-0432.ccr-03-0760 (2004).
11. Kuang, D. M. et al. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. Journal of hepatology 54, 948-955, doi: 10.1016/j.jhep.2010.08.041 (2011).
12. Sun, Z. & Yang, P. Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. The Lancet. Oncology 5, 182-190, doi: 10.1016/s1470-2045(04)01414-7 (2004).
13. Horne, Z. D. et al. Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer. The Journal of surgical research 171, 1-5, doi: 10.1016/j.jss.2011.03.068 (2011).
14. Krenn-Pilko, S. et al. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients. British journal of cancer 110, 2524-2530, doi: 10.1038/bjc.2014.163 (2014).
15. Stotz, M. et al. The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. British journal of cancer 110, 435-440, doi: 10.1038/bjc.2013.785 (2014).
16. Limaye, A. R. et al. Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 43, 757-764, doi: 10.1111/hepr.12019 (2013).
17. Hu, K., Lou, L., Ye, J. & Zhang, S. Prognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysis. BMJ open 5, e006404, doi: 10.1136/bmjopen-2014-006404 (2015).
18. Zhang, X., Zhang, W. & Feng, L. J. Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a metaanalysis. PloS one 9, e111906, doi: 10.1371/journal.pone.0111906 (2014).
19. Unal, D., Eroglu, C., Kurtul, N., Oguz, A. & Tasdemir, A. Are Neutrophil/Lymphocyte and Platelet/Lymphocyte Rates in Patients with Non-Small Cell Lung Cancer Associated with Treatment Response and Prognosis? Asian Pac. J. Cancer Prev. 14, 5237-5242, doi: 10.7314/apjcp.2013.14.9.5237 (2013).
20. Yao, Y. W., Yuan, D. M., Liu, H. B., Gu, X. L. & Song, Y. Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy. Cancer Immunology Immunotherapy 62, 471-479, doi: 10.1007/s00262-012-1347-9 (2013).
21. Cannon, N. A. et al. Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors following stereotactic radiation therapy for early-stage non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, doi: 10.1097/jto.0000000000000399 (2014).
22. Kacan, T. et al. Could the Neutrophil to Lymphocyte Ratio be a Poor Prognostic Factor for Non Small Cell Lung Cancers? Asian Pac. J. Cancer Prev. 15, 2089-2094, doi: 10.7314/apjcp.2014.15.5.2089 (2014).
23. Pinato, D. J. et al. Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer. British journal of cancer, doi: 10.1038/bjc.2014.145. (2014).
24. Lee, Y. et al. Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy. Journal of cancer research and clinical oncology 138, 2009-2016 (2012).
25. Teramukai, S. et al. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03. European journal of cancer 45, 1950-1958, doi: 10.1016/j. ejca.2009.01.023 (2009).
26. Tomita, M., Shimizu, T., Ayabe, T., Yonei, A. & Onitsuka, T. Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer. Anticancer research 31, 2995-2998 (2011).
27. Cedres, S. et al. Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 14, 864-869, doi: 10.1007/s12094-012-0872-5 (2012).
28. Botta, C. et al. Systemic inlammatory status at baseline predicts bevacizumab beneit in advanced non-small cell lung cancer patients. Cancer Biology and Therapy 14, 469-475 (2013).
29. Forget, P. et al. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery. Annals of surgical oncology 20 Suppl 3, S650-660, doi: 10.1245/s10434-013-3136-x (2013).
30. Jafri, S. H., Shi, R. & Mills, G. Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): A retrospective review. BMC cancer 13, doi: 10.1186/1471-2407-13-158. (2013).
31. Lin, G. N. et al. Elevated neutrophil-to-lymphocyte ratio predicts poor outcome in patients with advanced non-small-cell lung cancer receiving first-line gefitinib or erlotinib treatment. Asia Pac J Clin Oncol, doi: 10.1111/ajco.12273 (2014).
32. Choi, J. E. et al. Perioperative neutrophil:lymphocyte ratio and postoperative NSAID use as predictors of survival after lung cancer surgery: a retrospective study. Cancer medicine, doi: 10.1002/cam4.428 (2015).
33. E, Y., He, N., Wang, Y. & Fan, H. Percutaneous transluminal angioplasty (PTA) alone versus PTA with balloon-expandable stent placement for short-segment femoropopliteal artery disease: a metaanalysis of randomized trials. Journal of vascular and interventional radiology : JVIR 19, 499-503, doi: 10.1016/j.jvir.2007.12.446 (2008).
34. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674, doi: 10.1016/j.cell.2011.02.013 (2011).
35. Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454, 436-444, doi: 10.1038/nature07205 (2008).
36. Pillay, J. et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. Journal of Clinical Investigation 122, 327-336, doi: 10.1172/jci57990 (2012).
37. Motomura, T. et al. Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. Journal of hepatology 58, 58-64, doi: 10.1016/j.jhep.2012.08.017 (2013).
38. Yang, X., Huang, Y., Feng, J. F. & Liu, J. S. Prognostic significance of neutrophil-to-lymphocyte ratio in esophageal cancer: a meta-analysis. OncoTargets and therapy 8, 789-794, doi: 10.2147/ott.s77099 (2015).
39. Yang, J. J. et al. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis. World journal of gastroenterology : WJG 21, 2807-2815, doi: 10.3748/wjg.v21.i9.2807 (2015).
40. Xiao, W.-K. et al. Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis. Bmc Cancer 14, doi: 10.1186/1471-2407-14-117 (2014).
41. Li, M.-X. et al. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis. International Journal of Cancer 134, 2403-2413, doi: 10.1002/ijc.28536 (2014).
42. Tierney, J. F., Stewart, L. A., Ghersi, D., Burdett, S. & Sydes, M. R. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8, 16, doi: 10.1186/1745-6215-8-16 (2007).